Moneycontrol
HomeNewsBusinessIndia, US to increase engagement to address issues in medical devices trade
Trending Topics

India, US to increase engagement to address issues in medical devices trade

The issue came up for discussion during the 14th Trade Policy Forum (TPF) meeting here. It was co-chaired by US Trade Representative Katherine Tai and Commerce and Industry Minister Piyush Goyal here.

January 12, 2024 / 23:04 IST
Story continues below Advertisement

India, US to increase engagement to address issues in medical devices trade

India and the US on Friday agreed to increase engagement to resolve various issues that could negatively impact the trade in the medical devices sector. The issue came up for discussion during the 14th Trade Policy Forum (TPF) meeting here. It was co-chaired by US Trade Representative Katherine Tai and Commerce and Industry Minister Piyush Goyal here.

According to a joint statement, both ministers acknowledged the need to ensure patient access to affordable medical devices, including through the Trade Margin Rationalization (TMR) approach. "They also emphasised the importance of enhancing engagement to address measures that could negatively impact the ongoing trade in the sector, such as standards and pricing issues for medical devices, including for cardiac stents and knee implants," it said.

Story continues below Advertisement

The two sides also noted that this engagement would facilitate access to cutting-edge medical technology for patients. The ministers shared concerns related to the over-dependence and lack of diversity in Active Pharmaceutical Ingredients (APIs) within the global pharmaceutical supply chain and welcomed the opportunity to collaborate to de-risk and diversify with a focus on key starting materials.

They also emphasised their mutual interest in furthering public health discussions to ensure safe and effective medical products. "India emphasised the need to increase the number of inspections by the US Food and Drug Administration (US FDA) in India to facilitate trade and continue to reduce the backlog," the statement said, adding the US appreciated India's remarks, noting that the US FDA has increased staffing to increase pharmaceutical inspections conducted by the agency.